Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes
Maria I. Carlo(Memorial Sloan Kettering Cancer Center), Chung‐Han Lee(Memorial Sloan Kettering Cancer Center), Darren R. Feldman(Memorial Sloan Kettering Cancer Center), James J. Hsieh(Memorial Sloan Kettering Cancer Center), Yelena Kemel(Kettering University), Gouri J. Nanjangud(Memorial Sloan Kettering Cancer Center), Joshua Chaim(Cornell University), Robert J. Motzer(Memorial Sloan Kettering Cancer Center), Kaitlin M. Woo(Cornell University), Sujata Patil(Kettering University), Alison M. Schram(Memorial Sloan Kettering Cancer Center), A. Ari Hakimi(Penn State Milton S. Hershey Medical Center), Ying‐Bei Chen(Memorial Sloan Kettering Cancer Center), Martin H. Voss(Memorial Sloan Kettering Cancer Center), Devyn Taylor Coskey(Memorial Sloan Kettering Cancer Center)
Cited by 58
Related Papers
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
|New England Journal of Medicine|2018|4.6k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k